Experiment set20IT048 for Pseudomonas simiae WCS417

Compare to:

Supernatant; Trichoderma atroviride IMI dcr22mutant grown in Vogels_fungal_media, filtered; 0.8X

Group: supernatant
Media: R2A + supernatant from Trichoderma atroviride IMI dcr22mutant grown in Vogels_fungal_media, filtered (0.8 X)
Culturing: fluoroDangl_ML3, 24-well transparent microplate; Multitron, Aerobic, at 30 (C), shaken=700 rpm
By: Cat_Manuel on 1-Feb-22
Media components: 0.5 g/L Bacto Peptone, 0.5 g/L casamino acids, 0.5 g/L Yeast Extract, 0.5 g/L D-Glucose, 0.5 g/L Starch, 0.3 g/L Potassium phosphate dibasic, 0.05 g/L Magnesium Sulfate Heptahydrate, 0.3 g/L Sodium pyruvate

Specific Phenotypes

For 25 genes in this experiment

For supernatant Supernatant; Trichoderma atroviride IMI dcr22mutant grown in Vogels_fungal_media, filtered in Pseudomonas simiae WCS417

For supernatant Supernatant; Trichoderma atroviride IMI dcr22mutant grown in Vogels_fungal_media, filtered across organisms

SEED Subsystems

Subsystem #Specific
Campylobacter Iron Metabolism 2
Cobalt-zinc-cadmium resistance 2
Iron acquisition in Vibrio 2
Lysine degradation 2
Transport of Iron 2
Pyruvate Alanine Serine Interconversions 1
Rhamnose containing glycans 1
Siderophore Pyoverdine 1
Ton and Tol transport systems 1
dTDP-rhamnose synthesis 1
linker unit-arabinogalactan synthesis 1

Metabolic Maps

Color code by fitness: see overview map or list of maps.

Maps containing gene(s) with specific phenotypes:

MetaCyc Pathways

Pathways that contain genes with specific phenotypes:

Pathway #Steps #Present #Specific
β-alanine degradation II 2 2 1
putrescine degradation V 2 2 1
4-aminobutanoate degradation I 2 2 1
4-aminobutanoate degradation III 2 2 1
4-aminobutanoate degradation II 2 1 1
benzimidazolyl adenosylcobamide biosynthesis from adenosylcobinamide-GDP 3 3 1
adeninyl adenosylcobamide biosynthesis from adenosylcobinamide-GDP 3 3 1
5-methoxy-6-methylbenzimidazolyl adenosylcobamide biosynthesis from adenosylcobinamide-GDP 3 3 1
5-methylbenzimidazolyl adenosylcobamide biosynthesis from adenosylcobinamide-GDP 3 3 1
adenosylcobalamin biosynthesis from adenosylcobinamide-GDP I 3 3 1
5-methoxybenzimidazolyl adenosylcobamide biosynthesis from adenosylcobinamide-GDP 3 3 1
2-methyladeninyl adenosylcobamide biosynthesis from adenosylcobinamide-GDP 3 3 1
5-hydroxybenzimidazolyl adenosylcobamide biosynthesis from adenosylcobinamide-GDP 3 3 1
phenyl adenosylcobamide biosynthesis from adenosylcobinamide-GDP 3 2 1
superpathway of 4-aminobutanoate degradation 3 2 1
4-methylphenyl adenosylcobamide biosynthesis from adenosylcobinamide-GDP 3 2 1
GABA shunt II 4 3 1
adenosylcobalamin biosynthesis from adenosylcobinamide-GDP II 4 2 1
GABA shunt I 4 2 1
dTDP-β-L-rhamnose biosynthesis 5 5 1
β-alanine biosynthesis II 6 5 1
4-aminobutanoate degradation V 7 2 1
superpathway of adenosylcobalamin salvage from cobinamide I 8 8 1
superpathway of adenosylcobalamin salvage from cobinamide II 9 8 1
superpathway of coenzyme A biosynthesis II (plants) 10 9 1
O-antigen building blocks biosynthesis (E. coli) 11 10 1
superpathway of L-arginine, putrescine, and 4-aminobutanoate degradation 11 8 1
superpathway of L-arginine and L-ornithine degradation 13 10 1
nicotine degradation I (pyridine pathway) 17 4 1
superpathway of dTDP-glucose-derived O-antigen building blocks biosynthesis 19 5 1
adenosylcobalamin biosynthesis II (aerobic) 33 31 1
superpathway of mycolyl-arabinogalactan-peptidoglycan complex biosynthesis 33 12 1
adenosylcobalamin biosynthesis I (anaerobic) 36 28 1